Abstract
The formation and potential function of arachidonic acid metabolites in brain are reviewed briefly. Cyclooxygenase metabolites of arachidonic acid are formed in brain, but the lipoxygenase derivatives have not been demonstrated. Evidence clearly indicates that the cyclooxygenase products act as neuromodulators. Possible effects of leukotrienes on brain function remain in doubt, although several studies have suggested a role for the leukotrienes and it appears that these agents have a long-lasting effect. Potential interactions between ethanol and brain arachidonic acid metabolites have received minimal attention. Several studies indicate that pretreatment with prostaglandin synthetase inhibitors produces antagonism of ethanol’s behavioral effects. These observations may be related to preliminary findings that ethanol increases brain prostaglandin content.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bergstrom S, Farnebo L-O, Fuxe K: Effect of prostaglandin E2 on central and peripheral catecholamine neurons. Eur J Pharmacol 21:362–368, 1973.
Clark JW, Kalant H, Carmichael FJ: Effect of ethanol tolerance on release of acetylcholine and norepinephrine by rat cerebral cortex slices. Can J Physiol Phamacol 55:758–768, 1977.
Sun AY: Alcohol-membrane interactions in the brain: Norepinephrine release. Res Commun Chem Pathol Pharmacol 15:705–719, 1976.
Wolfe LS: Eicosanoids: Prostaglandins, thromboxanes, leukotrienes, and other derivatives of carbon-20 unsaturated fatty acids. J Neurochem 38:1–14, 1982.
Abdel-Halim MS, Anggård G: Regional and species differences in endogenous prostaglandin biosynthesis by brain homogenates. Prostaglandins 17:411–418, 1979.
Sautebin L, Spagnuolo C, Galli C, et al: A mass fragmentographic procedure for the simultaneous determination of HETE and PGF2α in the central nervous system. Prostaglandins 16:985–988, 1978.
Spagnuolo C, Sautebin L, Galli C, et al: PGF2, thromboxane B2 and HETE levels in gerbil brain cortex after ligation of common carotid arteries and decapitation. Prostaglandins 18:53–61, 1979.
Bosisio E, Galli C, Galli G, et al: Correlation between release of free arachidonic acid and prostaglandin formation in brain cortex and cerebellum. Prostaglandins 11:773–781, 1976.
Horrocks LA, Van Rollins M, Yates AJ: Lipid changes in the ageing brain, in Davison AN, Thompson RHS (eds): Molecular Basis of Neuropathology. Great Britain, Edward Arnold Publishers, 1981, pp 601–630.
Wolfe LS: Possible roles of prostaglandins in the nervous system, in Aprison M, Agranoff BW (eds): Advances in Neurochemistry, vol 1. New York, Plenum Press, 1975, pp 1–49.
Bito LZ, Davson H, Hollingsworth JR: Facilitated transport of prostaglandins across the blood-cerebrospinal fluid and blood-brain barriers. J Physiol 256:273–285, 1976.
Shimizu T, Mizuno N, Amano T, et al: Prostaglandin D2, a neuromodulator. Proc Natl Acad Sci USA 76:6231–6234, 1979.
Palmer MR, Mathews WR, Hoffer BJ, et al: Electrophysiological response of cerebellar Purkinje neurons to leukotriene D4 and B4. J Pharmacol Exp Ther 219:91–96, 1981.
Hayaishi O: Prostaglandin D2: A neuromodulator. Adv Prost Thrombox Leuk Res 12:333–337, 1983.
Kondo K, Shimizu T, Hayaishi O: Effects of prostaglandin D2 on membrane potential in neuroblastoma X glioma hybrid cells as determined with a cyanine dye. Biochem Biophys Res Commun 98:648–655, 1981.
Hemker DP, Aiken JW: Modulation of autonomic neurotransmissions by PGD2: Comparison with effects of other prostaglandins in anesthetized cats. Prostaglandins 20:321–332, 1980.
Wendel OT, Strandhov JW: The effects of prostaglandin E2 and F2α on synaptosomal accumulation and release of (3H) norepinephrine). Prostaglandins 116:441–449, 1978.
Howlett AC: Stimulation of neuroblastoma adenylate cyclase by arachidonic acid metabolites. Mol Pharmacol 21:664–670, 1982.
Hillier K, Templeton WW: Stimulation of prostaglandin synthesis in rat cerebral cortex via a ß-adrenoeeptor. Gen Pharmacol 13:21–26, 1982.
Coceani F, Pace-Asciak CR: Prostaglandins and the central nervous system, in Karim SMM (ed): Prostaglandins: Physiological, Pharmacological and Pathological Aspects. Lancaster, England, MTP Press, 1976, pp 1–36.
Dinarello CA, Bernheim HA: Ability of human leukocytic pyrogen to stimulate prostaglandin synthesis in vitro. J Neurochem 37:702–708, 1981.
Milton AS, Wendlandt S: Effects on body temperature of prostaglandins of the A, E and F series on injection into the third ventricle of unanesthetized cats and rabbits. J Physiol (London) 218:325–336, 1971.
Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action of aspirin-like drugs. Nature New Biol 231:232–235, 1971.
Baile CA, Simpson CW, Bena SM, et al: Prostaglandins and food intake of rats: A component of energy balance regulation. Physiol Behav 10:1077–1085, 1973.
Wishaw IQ, Veale WL: Comparison of the effect of prostaglandin E and norepinephrine injected into the brain on ingestive behavior in the rat. Pharmacol Biochem Behav 2:421–425, 1974.
Ragheb M, Ban TA: Prostaglandins and schizophrenia: A review. Prog Neuro-Psychopharmacol Biol Psychiatry 6:87–93, 1982.
Coupar IM, Taylor D: Alteration in the level of endogenous prostaglandins in hypothalamus induced by Δ9-tetrahydrocannabinol in the rat. Br J Pharmacol 76:115–120, 1982.
Ellis EF, Rosenblum WI, Birkle DL, et al: Lowering of brain levels of the depressant prostaglandin D2 by the antidepressant tranylcypromine. Biochem Pharmacol 31:1783–1784, 1982.
Kontos HA, Wei EP, Ellis EF, et al: Prostaglandins in physiological and in certain pathological responses of the cerebral circulation. Fed Proc 40:2326–2330, 1981.
Hagen AA, White RP, Robertson JT: Synthesis of prostaglandins and thromboxane B2 by cerebral arteries. Stroke 10:306–309, 1979.
Chan PH, Fishman RA, Caronna J: Induction of brain edema following intracerebral injection of arachidonic acid. Ann Neurol 13:625–633, 1983.
Siesjö BK, Wieloch T: Prostaglandins and the cerebral circulation. Adv Prost Thrombox Leuk Res 12:339–344, 1983.
Wilson CWM, Warnes H, Kirker JG, et al: The clinical symptom of migraine as a manifestation of allergic disease. Postgrad Med J 56:617–621, 1980.
Tageri P, DuBoulay G, Aitkin V, et al: Leukotriene D4 and the cerebral vasculature in vivo and in vitro. Prost Leuk Med 11:281–299, 1983.
Palmer MR, Mathews R, Murphy RC, et al: Leukotriene C elicits a prolonged excitation of cerebellar Purkinje neurons. Neurosci Lett 18:173–180, 1980.
Palmer RMJ, Stepney RJ, Higgs GA, et al: Chemokinetic activity of arachidonic acid lipoxygenase products on leukocytes of different species. Prostaglandins 20:411–418, 1980.
George FR, Collins AC: Prostaglandin synthetase inhibitors antagonize the depressant effects of ethanol. Pharmacol Biochem Behav 10:865–869, 1979.
George FR, Jackson SJ, Collins AC: Prostaglandin synthetase inhibitors antagonize hypothermia induced by sedative hypnotics. Psychopharmacology 74:241–244, 1981.
Ritz MC, George FR, Collins AC: Indomethacin antagonizes ethanol-induced but not pen-tobarbital-induced behavioral activation. Subst Alcohol Actions Misuse 2:289–299, 1981.
George FR, Howerton TC, Elmer Gl, et al: Antagonism of alcohol hypnosis by blockade of prostaglandin synthesis and activity: Genotype and time course effects. Pharmacol Biochem Behav 19:131–136, 1983.
McClearn GE, Kakihana R: Selective breeding for ethanol sensitivity: Short-sleep and long-sleep mice, in McClearn GE, Deitrich RA, Erwin VG (eds): Development of Animal Models as Pharmacogenetic Tools, DHHS Publication No. [ADM 81-1133]. Washington, DC, US Government Printing Office, 1981, pp 147–159.
Rotrosen J, Mandio D, Segarnick D, et al: Ethanol and prostaglandin E1. Biochemical and behavioral interactions. Life Sci 26:1867–1876, 1980.
Rosenkranz RP: Effects of intracerebroventricular administration of PGE1, E2 and F2α on electrically induced convulsions in mice. Prostaglandins 15:925–942, 1978.
Rosenkranz RP, Killam KF: Effects of intracerebroventricular administration of prostaglandin E1 and E2 on chemically induced convulsions in mice. J Pharmacol Exp Ther 209:231–237, 1979.
Stuart MJ: Ethanol-inhibited platelet prostaglandin synthesis in vitro. J Stud Alcohol 40:1–6, 1979.
Hwang DH, LeBlanc P, Chanmugan P: In vitro and in vivo effects of ethanol on the formation of endoperoxide metabolites in rat platelets. Lipids 16:583–588, 1981.
Kontula K, Viinikka L, Ylikorkala O, et al: Effect of acute ethanol intake on thromboxane and prostacyclin in humans. Life Sci 31:261–264, 1982.
Kangasaho M, Hillbom M, Kaste M, et al: Effect of ethanol intoxication and hangover on plasma levels of thromboxane B2 and 6-ketoprostaglandin Flα and on thromboxane B2 formation by platelets in man. Thromb Haemostasis 48:232–234, 1982.
Anton RF, Randall CL, Wallis CJ, et al: Effect of acute alcohol exposure on in vivo brain cortical PGE levels in C3H mice. Alcohol Clin Exp Res 7:104, 1983.
George FR, Elmer GI, Ritz MC, et al: Ethanol differentially increases in vivo brain prostaglandin levels in LS vs. SS mice: A dose-response analysis. Behav Genet 13:534–535, 1983.
George FR, Ritz MC, Elmer GI, et al: Time course for ethanol-induced changes in in vivo brain prostaglandin levels in LS and SS mice. Behav Genet 13:535, 1983.
Bishai F, Coceani F: Transformation of prostaglandin H2 in the cat brain. Biochim Biophys Acta 664:1–9, 1981.
Egg D, Herold M, Rumpl E, et al: Prostaglandin F2α levels in human cerebrospinal fluid in normal and pathological conditions. J Neurol 222:239–248, 1980.
Goehlert UG, Ng Ying Kin NMK, Wolfe LS: Biosynthesis of prostacyclin in rat cerebral microvessels and choroid plexus. J Neurochem 36:1192–1201, 1981.
Tansik RL, White HL: Prostaglandin synthesis in homogenates of cultured neuroblastoma cells. Prostaglandins Med 2:225–234, 1979.
Rigast A, Levine L: Effect of propranolol on arachidonic acid metabolism by cells in culture. Prostaglandins Med 7:217–228, 1981.
Abdel-Halim MS, Hamberg M, Sjoquist B, et al: Identification of prostaglandin D2 as the major prostaglandin in homogenates of rat brain. Prostaglandins 14:633–643, 1977.
Abdel-Halim MS, Lunden I, Cseh G, et al: Prostaglandin profiles in nervous tissue and blood vessels of brain of various animals. Prostaglandins 19:249–258, 1980.
Capdevilla J, Chacos N, Falck JR, et al: Novel hypothalamic arachidonate products stimulate somatostatin release from the median eminence. Endocrinology 113:421–427, 1983.
Forstermann U, Heldt R, Knappen F, et al: Potential anticonvulsive properties of endogenous prostaglandins formed in mouse brain. Brain Res 240:303–310, 1982.
Birkle DL, Ellis EF: Conversion of arachidonic acid to cyclooxygenase and lipoxygenase products, and incorporation into phospholipids in the mouse neuroblastoma clone, neuro-2A. Neurochem Res 8:319–332, 1983.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Plenum Press, New York
About this chapter
Cite this chapter
Westcott, J.Y., Collins, A.C. (1985). Brain Arachidonic Acid Metabolites Functions and Interactions with Ethanol. In: Galanter, M. (eds) Recent Developments in Alcoholism. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-7715-7_10
Download citation
DOI: https://doi.org/10.1007/978-1-4615-7715-7_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-7717-1
Online ISBN: 978-1-4615-7715-7
eBook Packages: Springer Book Archive